Iridex (IRIX) Liabilities from Discontinued Operations (2011 - 2012)
Iridex's (IRIX) quarterly Liabilities from Discontinued Operations came in at 67000.0 in Q3 2012, down 15.19% quarter-over-quarter from 79000.0 in Q2 2012.
Iridex (IRIX) Liabilities from Discontinued Operations (2011 - 2012) Analysis & Trends
Iridex's Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 67000.0 for Q3 2012.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 67000.0 in Q3 2012; TTM through Sep 2012 was 67000.0, a N/A change from a year earlier, with the FY2011 full-year figure at 2663000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations slipped to 67000.0 in Q3 2012 per IRIX's latest filing, from 79000.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 2663000.0 in Q4 2011 and bottomed at 67000.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 29, 2012 | 67,000.00 |
| Sep 29, 2012 | 67,000.00 |
| Jun 30, 2012 | 79,000.00 |
| Jun 30, 2012 | 79,000.00 |
| Mar 31, 2012 | 259,000.00 |
| Mar 31, 2012 | 259,000.00 |
| Dec 31, 2011 | 2.66 Mn |
| Dec 31, 2011 | 2.66 Mn |